The latest thoracic oncology news
Novel AI blood testing technology can ID lung cancers with high accuracy
A novel artificial intelligence blood testing technology developed by researchers at the Johns Hopkins Kimmel…
Browsing: Lung Cancer
A cost-effective anti-angiogenic drug to treat lung cancer is finally here
In 2018, lung cancer caused 1.8 million cancer deaths worldwide. It is the most common…
Model to predict non-small cell lung cancer patient outcomes to immunotherapy developed
Immunotherapy agents that inhibit the molecules PD1, PD-L1 or CTLA-4 have become widely used in…
Novel AI blood testing tech detects over 90% of lung cancers
A novel artificial intelligence blood testing technology developed by researchers at the Johns Hopkins Kimmel…
Cell therapy–checkpoint inhibitor combo shows promise in non-small cell lung cancer
Immunotherapy has become an important tool in the treatment of lung cancer, especially checkpoint inhibitors that…
TOGA Annual Scientific Meeting 2021 Report
The Thoracic Oncology Group of Australasia (TOGA) was established in 2020 as the lead independent…
Novel therapy shows promise for lung cancer patients with rare EGFR mutation
Lung cancer is the leading cause of cancer death among men and women in the…
Impact of KRAS isoforms in human cancers
KRAS was one of the first oncogenes to be identified, a few decades ago. It…
Quitting smoking after lung cancer diagnosis may extend life without cancer recurrence
A prospective cohort study found that quitting smoking after being diagnosed with early-stage non-small cell…
Study identifies MET amplification as driver for some non-small cell lung cancers
A study led by D. Ross Camidge, MD, PhD, director of thoracic oncology at the…